Hiv Infection
HIV PrEP Curbside Consults: Cisgender Pregnant Female With an HIV Positive Partner
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
HIV PrEP Curbside Consults: Adolescent Transgender Male Who Engages in High-Risk Behaviors
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
HIV PrEP Curbside Consults: Black MSM Who Engages in High-Risk Behaviors
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
HIV PrEP Curbside Consults: Older Transgender Female Who Is Sexually Active
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
FDA sets date for decision on twice-yearly shots to prevent HIV
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV infection and set a date of June 19 to decide on its approval, Gilead announced Tuesday.
No HIV vaccine on the horizon but research shows other tools, efforts are plentiful
Although there is still no HIV vaccine and no promising candidates in the pipeline, data published throughout 2024 show the significant impacts of prevention efforts and tools.
Despite improvement in new PrEP use, racial, ethnic ‘disparities still persist’
Access to pre-exposure prophylaxis remains insufficient, especially among Black, Hispanic and Medicare-insured populations, results of an analysis presented at IDWeek suggested.
A vaginal ring could soon offer women 3 months of HIV protection
Lima, PERU — Choice, long-lasting protection and HIV prevention in women were three major themes of this week’s HIV Research for Prevention conference.
E-cigarette use associated with lower eosinophil counts among patients with HIV
BOSTON — The impact of e-cigarette use on eosinophil and basophil counts may depend on HIV serostatus, according to a study presented at the CHEST Annual Meeting.
Experimental HIV vaccines fail to reduce infections in trial
Two experimental HIV vaccine regimens failed to reduce infections in a 3-year trial in eastern and southern Africa compared with participants who were taking a placebo, some of whom were on oral PrEP, according to a study.